Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08-001

---
identifier: "/us/fr/E8-9671"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08-001"
title_number: 0
title_name: "Federal Register"
section_number: "E8-9671"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08-001"
positive_law: false
currency: "2008-05-02"
last_updated: "2008-05-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E8-9671"
document_type: "notice"
publication_date: "2008-05-02"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "73 FR 24291"
fr_volume: 73
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings, Funding Opportunity Announcement (FOA) CI08-001

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

*Time and Date:* 12 p.m.-3 p.m., May 20, 2008 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters To Be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to “Development, Implementation and Evaluation of Novel Strategies To Reduce Inappropriate Antimicrobial Use in Community and Healthcare Settings,” FOA CI08-001.

*Contact Person for More Information:* Christine Morrison, PhD, Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D74, Atlanta, GA 30333, Telephone 404-639-3098.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 28, 2008.

Diane Allen,

Acting Director, Management Analysis and Services Office,  Centers for Disease Control and Prevention.